Q11207 (Q11207): Difference between revisions
Jump to navigation
Jump to search
(Removed claims) |
(Changed an Item) |
||||||||||||||
| Property / EU contribution | |||||||||||||||
4,208,983.49 Czech koruna
| |||||||||||||||
| Property / EU contribution: 4,208,983.49 Czech koruna / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / EU contribution | |||||||||||||||
168,359.3396 Euro
| |||||||||||||||
| Property / EU contribution: 168,359.3396 Euro / rank | |||||||||||||||
Preferred rank | |||||||||||||||
| Property / EU contribution: 168,359.3396 Euro / qualifier | |||||||||||||||
exchange rate to Euro: 0.04 Euro
| |||||||||||||||
| Property / EU contribution: 168,359.3396 Euro / qualifier | |||||||||||||||
point in time: 10 January 2020
| |||||||||||||||
| Property / budget | |||||||||||||||
10,525,090.0 Czech koruna
| |||||||||||||||
| Property / budget: 10,525,090.0 Czech koruna / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / budget | |||||||||||||||
421,003.60000000003 Euro
| |||||||||||||||
| Property / budget: 421,003.60000000003 Euro / rank | |||||||||||||||
Preferred rank | |||||||||||||||
| Property / budget: 421,003.60000000003 Euro / qualifier | |||||||||||||||
exchange rate to Euro: 0.04 Euro
| |||||||||||||||
| Property / budget: 421,003.60000000003 Euro / qualifier | |||||||||||||||
point in time: 10 January 2020
| |||||||||||||||
Revision as of 00:19, 12 February 2020
Project in Czech Republic financed by DG Regio
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | No label defined |
Project in Czech Republic financed by DG Regio |
Statements
4,208,983.49 Czech koruna
0 references
10,525,090.0 Czech koruna
0 references
39.9899999904989 percent
0 references
20 April 2017
0 references
18 April 2020
0 references
EXBIO Praha, a.s.
0 references
49°59'0.49"N, 14°30'9.11"E
0 references
25250
0 references
Projekt je zaměřen na VaV technologie přípravy specifických fluorescenčních značek, tzv. tandemových fluorochromů, která umožní výrobu skupiny produktů - In vitro diagnostických (IVD) zdravotnických prostředků pro identifikaci maligních, reaktivních a normálních krevních buněk v klinických vzorcích pomocí průtokové cytometrie. Splněním požadavků regulace 21 CFR 820 bude zaručena možnost registrace nových produktů pro klinické aplikace na celosvětových trzích, včetně USA. a. (Czech)
0 references
Identifiers
CZ.01.1.02/0.0/0.0/16_083/0010233
0 references